
Vigibose 0.3mg Tablet
Marketer
Xenon Pharmaceuticals
Salt Composition
Voglibose (0.3mg)
Overview Vigibose 0.3mg Tablet
Diabetol 0.3mg tablets are prescribed for managing type 2 diabetes. This medication helps regulate elevated blood glucose post-meal. It's indicated when dietary modifications and other comparable medications prove insufficient in controlling hyperglycemia. Diabetol 0.3mg should be ingested immediately before meals. Dosage frequency is determined individually by your physician to optimize blood sugar control. Abrupt cessation requires medical consultation; otherwise, hyperglycemia and serious complications such as renal impairment or vision loss may arise. This treatment forms part of a comprehensive approach encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Regular blood glucose monitoring is crucial during treatment. Commonly reported side effects include flatulence, abdominal discomfort, appetite suppression, constipation, and diarrhea. Persistent or bothersome side effects necessitate medical attention. While Diabetol 0.3mg itself doesn't induce hypoglycemia, concomitant use with other anti-diabetic agents (particularly insulin or sulfonylureas) may lead to low blood sugar. Glucose (dextrose) is the appropriate countermeasure; sucrose is ineffective. Prior to commencing treatment, inform your physician of any hepatic or renal conditions. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should seek medical advice before use. Complete disclosure of all medications is essential for safe usage. Excessive alcohol consumption should be avoided due to the heightened risk of hypoglycemia.
Primary Ingredients of Vigibose 0.3mg Tablet
The provided text is "undefined," which cannot be rephrased while maintaining meaning and intent. There is no text to rewrite.
Uses of Vigibose 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Vigibose 0.3mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 0.3mg Vigibose tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
Common Side effects of Vigibose 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vigibose 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vigibose 0.3mg Tablet on an empty stomach.
How Vigibose 0.3mg Tablet works:
Vigibose 0.3mg tablets manage blood sugar by blocking intestinal enzymes that digest complex carbohydrates. This action reduces post-meal spikes in blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vigibose 0.3mg Tablet with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Vigibose 0.3mg tablets is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; however, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Vigibose 0.3mg tablets without significant risk to their infants. Available human data indicates minimal potential harm to the baby.
DrivingSAFE
Driving ability is typically unaffected by Vigibose 0.3mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Vigibose 0.3mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Vigibose 0.3mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Vigibose 0.3mg Tablet :
Omit any missed dose of Vigibose 0.3mg Tablet and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Vigibose 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Alpha-glucosidase inhibitors |
